http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006136806-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd708a84f841d099bd81f8e8d72a610a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-70
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F17-21
filingDate 2005-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b79f3e1a00742aa40e41e4377ad7d68a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6765dda724c9ecd647bb2829427669ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60229266201f4fdd2c937b2ad87edbf2
publicationDate 2006-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2006136806-A1
titleOfInvention System and method for analysis of neurological condition
abstract Embodiments of the present invention comprise computer-based tools facilitating visualization and assessment of progression of neurological disorders in a patient. In one embodiment, data is received in the form of the results of standardized neurological examination of the patient. This input is compared to a rule set defining progression of the disorder, and the results of this comparison are displayed in an electronic document featuring internal links. The data may be displayed as tables and/or charts, with elapsed time plotted along a row/column or axis, respectively. Progression indication may be displayed through changed color. The electronic document can also display data not directly relevant to neurological condition, for example medication and radiation treatment schedules. By automatically displaying the data and the derived progression assessment according to the rule set, embodiments of the present invention are of particularly use in rapidly and uniformly evaluating treatment therapies.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11017323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012135654-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011267946-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011159592-A1
priorityDate 2004-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6561992-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5812983-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6463321-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6767325-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004249251-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004199332-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6306087-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002103512-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002138512-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003088177-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6764447-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004143461-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6684188-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6746399-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6223074-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003129134-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6817980-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID180103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9919910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395290
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID180103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493846

Total number of triples: 45.